TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36007987

Group type: EXPERIMENTAL
Intervention: Evolocumab (proprotein convertase subtilisin‐kexin type 9 inhibitor)
Number of subjects: 27564
Study: 32776764

Group type: EXPERIMENTAL
Intervention: Prism adaptation
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 23
Study: 35958596

Group type: EXPERIMENTAL
Intervention: sIPV + DTaP concomitant administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: sIPV inoculation
Number of subjects: 0

Group type: COMPARATOR
Intervention: DTaP inoculation
Number of subjects: 0
Study: 33026154

Group type: EXPERIMENTAL
Intervention: High protein (HP) diet with high intensity physical activity (HI)
Number of subjects: 2326

Group type: COMPARATOR
Intervention: Moderate protein (MP) diet with moderate intensity physical activity (PA)
Number of subjects: 2326

Group type: EXPERIMENTAL
Intervention: Low glycaemic index (GI) diet with high intensity physical activity (HI)
Number of subjects: 2326

Group type: COMPARATOR
Intervention: Moderate protein (MP) diet with low glycaemic index (GI) and moderate intensity physical activity (PA)
Number of subjects: 2326
Study: 32003357

Group type: EXPERIMENTAL
Intervention: Endoscopic rubber band ligation (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Endoscopic injection sclerotherapy (Group A)
Number of subjects: 60
Study: 36409223

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 33501972

Group type: EXPERIMENTAL
Intervention: Antibiotic prescribing at visits that met criteria (205/214)
Number of subjects: 425

Group type: COMPARATOR
Intervention: Antibiotic prescribing at visits that did not meet criteria (193/211)
Number of subjects: 425
Study: 35232533

Group type: EXPERIMENTAL
Intervention: Video Modelling (VM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Picture Exchange Communication System (PECS)
Number of subjects: 50
Study: 32229722

Group type: EXPERIMENTAL
Intervention: Prehospital plasma
Number of subjects: 405
Study: 33834628

Group type: EXPERIMENTAL
Intervention: Remibrutinib (0.5‒600 mg)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Remibrutinib (>= 10 mg q.d.)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Remibrutinib (>= 50 mg q.d.)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Remibrutinib (>= 100 mg q.d.)
Number of subjects: 144
Study: 33054828

Group type: EXPERIMENTAL
Intervention: Thorough information about adverse effects
Number of subjects: 51

Group type: COMPARATOR
Intervention: Simple consent procedure
Number of subjects: 51
Study: 36305961

Group type: EXPERIMENTAL
Intervention: Almonds (15% of energy requirement)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Carbohydrate-rich snack bar (isocaloric)
Number of subjects: 140
Study: 32173730

Group type: EXPERIMENTAL
Intervention: Intravenous Tranexamic Acid (TXA) 1-g dose prior to skin incision and another 1-g dose 4 hours later
Number of subjects: 44

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 44
Study: 34187822

Group type: EXPERIMENTAL
Intervention: Surgical treatment for MSF
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-surgical treatment for MSF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Text messages to maximise data collection and participant retention
Number of subjects: 0
Study: 33157398

Group type: EXPERIMENTAL
Intervention: bare‐chested (fitspiration) images
Number of subjects: 300

Group type: COMPARATOR
Intervention: clothed (fashion) images
Number of subjects: 300

Group type: COMPARATOR
Intervention: scenery images
Number of subjects: 300
Study: 33497293

Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg · kg−1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (cellulose)
Number of subjects: 10
Study: 34096673

Group type: EXPERIMENTAL
Intervention: Glass-fibre post and composite resin core (Group F)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Custom PEEK post-core (Group P)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Custom zirconia post-core (Group Z)
Number of subjects: 120
Study: 35429794

Group type: EXPERIMENTAL
Intervention: Distant ischemic postconditioning (DIPC)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control
Number of subjects: 86
Study: 34267511

Group type: EXPERIMENTAL
Intervention: Handheld expiratory flowmeter (Vitalograph Ltd., COPD‐6®, Ireland)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Conventional spirometry
Number of subjects: 229
Study: 32087342

Group type: COMPARATOR
Intervention: self-monitoring (SM)
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: self-monitoring + feedback (SM + FB)
Number of subjects: 530
Study: 35946268

Group type: EXPERIMENTAL
Intervention: omega‐3 plus cetirizine
Number of subjects: 52

Group type: COMPARATOR
Intervention: cetirizine
Number of subjects: 52
Study: 36123569

Group type: EXPERIMENTAL
Intervention: Neuromuscular blockade (NMB) agent
Number of subjects: 30
Study: 33565308

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) with low dose prednisolone
Number of subjects: 37

Group type: COMPARATOR
Intervention: Cyclosporine (CsA) with low dose prednisolone
Number of subjects: 37
Study: 33303692

Group type: EXPERIMENTAL
Intervention: Mobile-based educational app
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard medical management (control)
Number of subjects: 66
Study: 33586783

Group type: EXPERIMENTAL
Intervention: 1X ST266
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 0.3X ST266
Number of subjects: 54

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 54
Study: 35767432

Group type: EXPERIMENTAL
Intervention: Traditional trance language (TTL)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Modern trance language (MTL)
Number of subjects: 178
Study: 33440342

Group type: EXPERIMENTAL
Intervention: LT + SMS
Number of subjects: 32

Group type: COMPARATOR
Intervention: LT
Number of subjects: 32
Study: 32897386

Group type: EXPERIMENTAL
Intervention: Anticoagulation Choice Shared Decision Making tool
Number of subjects: 922

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 922
Study: 36044948

Group type: EXPERIMENTAL
Intervention: Self-adhesive bulk-fill restorative (SABF, 3M)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional bulk-fill composite (Filtek One, 3M; FOBF)
Number of subjects: 30
Study: 34238026

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Coronary-artery bypass grafting (CABG)
Number of subjects: 600
Study: 35179709

Group type: EXPERIMENTAL
Intervention: AQCH 400 mg orally three times a day plus standard of care
Number of subjects: 210

Group type: COMPARATOR
Intervention: Standard of care alone
Number of subjects: 210
Study: 35935235

Group type: EXPERIMENTAL
Intervention: LTBI treatment (specific regimen not detailed)
Number of subjects: 100
Study: 32789962

Group type: EXPERIMENTAL
Intervention: Conventional CPB with selective pulmonary artery perfusion (study group, n = 12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional CPB (control group, n = 12)
Number of subjects: 24
Study: 34051293

Group type: EXPERIMENTAL
Intervention: Mirtazapine 15mg daily at night for 8 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 32571311

Group type: EXPERIMENTAL
Intervention: Joint frailty model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Negative binomial and shared frailty models
Number of subjects: 0
Study: 35690952

Group type: EXPERIMENTAL
Intervention: HoLEP
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: ThuFLEP
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 163
Study: 34143385

Group type: EXPERIMENTAL
Intervention: Helichrysum microphyllum subsp. tyrrhenicum planted in mine waste materials
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Helichrysum microphyllum subsp. tyrrhenicum planted in mine wastes with compost
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Helichrysum microphyllum subsp. tyrrhenicum planted in reference substrate
Number of subjects: 90
Study: 34515824

Group type: EXPERIMENTAL
Intervention: LSD 25μg
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: LSD 50μg
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: LSD 100μg
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: LSD 200μg
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: LSD (all doses combined)
Number of subjects: 83
Study: 34909900

Group type: EXPERIMENTAL
Intervention: 2% lidocaine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 2% tetracaine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 4% articaine
Number of subjects: 90

Group type: COMPARATOR
Intervention: 0.9% sodium chloride (NaCl)
Number of subjects: 90
Study: 34310640

Group type: EXPERIMENTAL
Intervention: Nurse-led hospital-to-home transitional care intervention
Number of subjects: 127

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 127
Study: 32196845

Group type: EXPERIMENTAL
Intervention: Plateletcrit (PCT)
Number of subjects: 0
Study: 36354034

Group type: EXPERIMENTAL
Intervention: Moxidectin (8 mg) and Albendazole (400 mg)
Number of subjects: 536

Group type: COMPARATOR
Intervention: Ivermectin (200 μg/kg) and Albendazole (400 mg)
Number of subjects: 536
Study: 33235299

Group type: COMPARATOR
Intervention: Transcutaneous tibial nerve stimulation (TASCI) intervention
Number of subjects: 640
Study: 32414425

Group type: EXPERIMENTAL
Intervention: Baricitinib 2 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baricitinib monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methotrexate monotherapy or combination therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baricitinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adalimumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daily diaries during interruptions
Number of subjects: 0
Study: 34595812

Group type: EXPERIMENTAL
Intervention: Ultra rapid lispro (URLi)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Humalog®
Number of subjects: 0
Study: 33611923

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sham TENS (Control)
Number of subjects: 52
Study: 35031340

Group type: EXPERIMENTAL
Intervention: SABR (Stereotactic Ablative Radiotherapy)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 62
Study: 36121246

Group type: EXPERIMENTAL
Intervention: Pulmonary artery denervation (PADN) plus a phosphodiesterase‐5 inhibitor (PDE‐5i)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Pulmonary artery denervation (PADN)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Sham procedure plus a phosphodiesterase‐5 inhibitor (PDE‐5i)
Number of subjects: 128
Study: 34322553

Group type: EXPERIMENTAL
Intervention: Pressure-regulated volume control (PRVC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pressure support ventilation (PSV)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Volume-controlled ventilation (VCV)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pressure-controlled ventilation (PCV)
Number of subjects: 30
Study: 32101034

Group type: EXPERIMENTAL
Intervention: Binge drinking video describing sexual impotence
Number of subjects: 353

Group type: COMPARATOR
Intervention: Cognitive or long-term deficits videos (not specified in detail)
Number of subjects: 353
Study: 35045351

Group type: EXPERIMENTAL
Intervention: Intravenous trehalose (15 g once weekly) for 12 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Intravenous trehalose
Number of subjects: 15
Study: 33562341

Group type: EXPERIMENTAL
Intervention: Montmorency tart cherry juice (240 mL once daily for 90 days)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Montmorency tart cherry juice (240 mL twice daily for 90 days)
Number of subjects: 27
Study: 35184885

Group type: EXPERIMENTAL
Intervention: Depth cutter (0.5 mm, Komet) (DC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Round bur (1.5 mm, Diatech) (RB)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Calibrated depth bur (laser mark of 0.5 mm, Gaofeng) (CD)
Number of subjects: 30
Study: 33142847

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) > 30 min five days per week
Number of subjects: 12641

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) > 30 min three to four days per week in high screen time (ST) group
Number of subjects: 12641

Group type: EXPERIMENTAL
Intervention: First-time smokers under 10 years
Number of subjects: 12641

Group type: EXPERIMENTAL
Intervention: High screen time (ST), low physical activity (PA), and smoking
Number of subjects: 12641

Group type: EXPERIMENTAL
Intervention: Adolescents from rural areas
Number of subjects: 12641
Study: 34480793

Group type: EXPERIMENTAL
Intervention: Compulsory military service
Number of subjects: 4029

Group type: EXPERIMENTAL
Intervention: Risk factors for back pain
Number of subjects: 4029

Group type: EXPERIMENTAL
Intervention: First months of military service
Number of subjects: 4029

Group type: EXPERIMENTAL
Intervention: General health care during military service
Number of subjects: 4029

Group type: EXPERIMENTAL
Intervention: Education and smoking prevention
Number of subjects: 4029
Study: 32534724

Group type: EXPERIMENTAL
Intervention: 8-hour time management workshop
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study: 34106555

Group type: EXPERIMENTAL
Intervention: Fetoscopic endoluminal tracheal occlusion (FETO)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Expectant care
Number of subjects: 196
Study: 32233268

Group type: EXPERIMENTAL
Intervention: Quality of care questionnaire
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Clinical remission
Number of subjects: 107
Study: 33903080

Group type: EXPERIMENTAL
Intervention: DM Expected Care Plan (ECP) Analyzer
Number of subjects: 115
Study: 32308189

Group type: EXPERIMENTAL
Intervention: OH (starter feed containing 10% DM basis oat hay)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: OH‐FC (starter feed containing 10% DM basis oat hay and oat hay fed as free‐choice provision in different buckets)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: FC (starter feed and oat hay fed as free‐choice provision in different buckets)
Number of subjects: 40

Group type: COMPARATOR
Intervention: CON (control, starter without oat hay)
Number of subjects: 40
Study: 36254421

Group type: EXPERIMENTAL
Intervention: Conventional septoplasty
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Endoscopic septoplasty using Freer's incision
Number of subjects: 70

Group type: COMPARATOR
Intervention: Comparison of post-operative mean SNOT-10 score between conventional and endoscopic techniques
Number of subjects: 70
Study: 35499912

Group type: EXPERIMENTAL
Intervention: Omega-3 (fish oil; 1440 mg/day of docosahexaenoic acid)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 60
Study: 34596090

Group type: EXPERIMENTAL
Intervention: Educational intervention for neonatal staff
Number of subjects: 166
Study: 33865366

Group type: EXPERIMENTAL
Intervention: Video-based online platform for surgical education
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard surgical textbooks
Number of subjects: 0
Study: 32472096

Group type: EXPERIMENTAL
Intervention: Deep learning classifier for histopathological images
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Deep learning classifier
Number of subjects: 388
Study: 36136596

Group type: EXPERIMENTAL
Intervention: Sleep Restriction (SR) - 5 hours time in bed for nine nights
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normal Sleep (NS) - ≥7 hours time in bed
Number of subjects: 10
Study: 33198488

Group type: EXPERIMENTAL
Intervention: Prostatic Urethral Lift
Number of subjects: 226
Study: 35291404

Group type: EXPERIMENTAL
Intervention: Ketofol (ketamine + propofol)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Isofol (isoflurane + propofol)
Number of subjects: 150
Study: 32915864

Group type: EXPERIMENTAL
Intervention: Social networking
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Online gaming
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Overall online activities
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Symptoms of PIU
Number of subjects: 812
Study: 35474254

Group type: EXPERIMENTAL
Intervention: Hormone therapy (HT) with oral micronized 17β-estradiol 1 mg/day for hysterectomized women and 4% vaginal micronized progesterone gel 45 mg/day for 10 days each month added to estradiol for women with a uterus.
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: Hormone therapy (HT)
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: Higher mean on-trial E2 levels
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: CIMT progression rate (μm/year)
Number of subjects: 643

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 643
Study: 33663779

Group type: EXPERIMENTAL
Intervention: TriGuard 3 (TG3)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control (no TG3)
Number of subjects: 220
Study: 32354466

Group type: EXPERIMENTAL
Intervention: Distraction cards
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Kaleidoscope
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 33574033

Group type: EXPERIMENTAL
Intervention: Personalised regimen
Number of subjects: 53

Group type: COMPARATOR
Intervention: Fixed regimen
Number of subjects: 53
Study: 34610519

Group type: EXPERIMENTAL
Intervention: Maladaptive cognitive emotion regulation strategies (men)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Adaptive cognitive emotion regulation strategies (women)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Adaptive cognitive emotion regulation strategies (men)
Number of subjects: 168
Study: 36109707

Group type: EXPERIMENTAL
Intervention: ReduRisk-program (n=357), comprising risk-adjusted delirium management, structured mobility training, and digitally supported planning of post-inpatient care, including polypharmacy management.
Number of subjects: 612

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: ReduRisk-program (n=357).
Number of subjects: 612
Study: 34639604

Group type: EXPERIMENTAL
Intervention: Synchronous online class group (SOCG)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Asynchronous online class group (AOCG)
Number of subjects: 54
Study: 32868544

Group type: EXPERIMENTAL
Intervention: 1g TXA bolus/1g TXA infusion (Bolus Maintenance [BM])
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: 2g TXA bolus/placebo infusion (Bolus Only [BO])
Number of subjects: 966

Group type: COMPARATOR
Intervention: Placebo bolus/placebo infusion (Placebo)
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: 1g TXA bolus/1g TXA infusion (Bolus Maintenance [BM]) and 2g TXA bolus/placebo infusion (Bolus Only)
Number of subjects: 966
Study: 35647824

Group type: EXPERIMENTAL
Intervention: 0.2% hyaluronic acid gel Gengigel®
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.01% hyaluronic acid spray Gengigel®
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (without HA)
Number of subjects: 30
Study: 34034792

Group type: EXPERIMENTAL
Intervention: AVATAR-brief (6 sessions) plus TAU
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: AVATAR-extended (12 sessions) plus TAU
Number of subjects: 345

Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 345
Study: 33530745

Group type: EXPERIMENTAL
Intervention: Erythropoietin (20,000 units) injected subcutaneously the day before, day of, and day after surgery for 3 doses
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Erythropoietin
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56

Group type: COMPARATOR
Intervention: Erythropoietin and Placebo
Number of subjects: 56
Study: 32489005

Group type: EXPERIMENTAL
Intervention: Self-regulation intervention using a weight tracking app and daily/weekly questionnaires
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (daily self-weighing without intervention)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Self-regulation intervention
Number of subjects: 100
Study: 36192751

Group type: EXPERIMENTAL
Intervention: Curcumin plus placebo (CP)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Coenzyme Q10 plus placebo (QP)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Curcumin plus coenzyme Q10 (CQ)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Double placebo (DP)
Number of subjects: 88
Study: 33118138

Group type: EXPERIMENTAL
Intervention: Smartphone application intervention (n=34)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Waitlist control group (n=34)
Number of subjects: 68
Study: 34526337

Group type: EXPERIMENTAL
Intervention: Perioperative care for enhanced recovery
Number of subjects: 260

Group type: COMPARATOR
Intervention: Conventional perioperative care
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Enhanced recovery protocol
Number of subjects: 260
Study: 35715856

Group type: EXPERIMENTAL
Intervention: Random Forest (RF) model for predicting xerostomia
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Decision Tree Classifier (DTC) model for predicting xerostomia
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Extreme-Gradient Boosting (XGB) model for predicting xerostomia
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Random Forest (RF) model for predicting Grade 3 xerostomia
Number of subjects: 365
Study: 33469794

Group type: EXPERIMENTAL
Intervention: Post-ERAS implementation
Number of subjects: 168

Group type: COMPARATOR
Intervention: Pre-ERAS implementation
Number of subjects: 168
Study: 35081856

Group type: EXPERIMENTAL
Intervention: Streaming music with a special binaural beat frequency (MBB)
Number of subjects: 267

Group type: COMPARATOR
Intervention: Streaming simple music (SM)
Number of subjects: 267

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 267
Study: 34281600

Group type: EXPERIMENTAL
Intervention: Suxiao Jiuxin Pill (SJP)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 324
Study: 33534904

Group type: EXPERIMENTAL
Intervention: Poisson binomial method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Midpoint and random-point methods
Number of subjects: 0
Study: 33230185

Group type: EXPERIMENTAL
Intervention: Periocular skin warming
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham eye mask
Number of subjects: 18